** Shares of Control Bionics rise 17.1% to A$0.082, on track for the best day since Aug. 19, if current gains hold
** Stock hits highest level since Sept. 12
** Medical device co received approvals of about A$400,000 ($273,720) from Australia's National Disability Insurance Scheme (NDIS) over the past eight weeks
** Amount higher than what co received from NDIS over last five months
** Says approvals will be recognized as revenue after devices are shipped to customers
** Stock adds ~22.4% in value so far this week, set for best week since Aug. 2
** More than 341,000 shares change hands by 0519 GMT, 1.4X 30-day avg volume of shares
** Stock up ~78.3% YTD, including current session's moves
($1 = 1.4603 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.